Alto Neuroscience (ANRO) Stock Forecast, Price Target & Predictions
ANRO Stock Forecast
Alto Neuroscience stock forecast is as follows: an average price target of $10.00 (represents a 150.00% upside from ANRO’s last price of $4.00) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.
ANRO Price Target
The average price target for Alto Neuroscience (ANRO) is $10.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $10.00. This represents a potential 150.00% upside from ANRO's last price of $4.00.
ANRO Analyst Ratings
According to 3 Wall Street analysts, Alto Neuroscience's rating consensus is 'Hold'. The analyst rating breakdown for ANRO stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Alto Neuroscience Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 23, 2024 | Brian Skorney | Robert W. Baird | $10.00 | $14.53 | -31.18% | 150.00% |
| Jun 20, 2024 | Brian Skorney | Robert W. Baird | $32.00 | $11.11 | 188.03% | 700.00% |
The latest Alto Neuroscience stock forecast, released on Oct 23, 2024 by Brian Skorney from Robert W. Baird, set a price target of $10.00, which represents a -31.18% decrease from the stock price at the time of the forecast ($14.53), and a 150.00% increase from ANRO last price ($4.00).
Alto Neuroscience Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 2 |
| Avg Price Target | - | $10.00 | $21.00 |
| Last Closing Price | $4.00 | $4.00 | $4.00 |
| Upside/Downside | -100.00% | 150.00% | 425.00% |
In the current month, the average price target of Alto Neuroscience stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Alto Neuroscience's last price of $4.00. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 23, 2024 | Wedbush | Outperform | Neutral | Downgrade |
| Oct 23, 2024 | Rodman & Renshaw | Buy | Neutral | Downgrade |
| Sep 10, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Sep 03, 2024 | Wedbush | Outperform | Initialise | |
| Jun 20, 2024 | Rodman & Renshaw | Buy | Initialise |
Alto Neuroscience's last stock rating was published by Wedbush on Oct 23, 2024. The company Downgrade its ANRO rating from "Outperform" to "Neutral".
Alto Neuroscience Financial Forecast
Alto Neuroscience Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
Alto Neuroscience's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ANRO's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Alto Neuroscience EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict ANRO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Alto Neuroscience's previous annual EBITDA (undefined) of $NaN.
Alto Neuroscience Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Alto Neuroscience's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ANRO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Alto Neuroscience SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
Alto Neuroscience's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ANRO last annual SG&A of $NaN (undefined).
Alto Neuroscience EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, Alto Neuroscience's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ANRO previous annual EPS of $NaN (undefined).